{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T20:01:05Z","timestamp":1793304065958,"version":"4.5.0"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,1]]},"DOI":"10.1097\/01.md.0000200467.51816.6d","type":"journal-article","created":{"date-parts":[[2006,3,6]],"date-time":"2006-03-06T04:01:28Z","timestamp":1141617688000},"page":"66-73","source":"Crossref","is-referenced-by-count":59,"title":["Lysozyme Amyloidosis"],"prefix":"10.1097","volume":"85","author":[{"given":"Brigitte","family":"Granel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Valleix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Serratrice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Ch\u00e9rin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Texeira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Disdier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Jean","family":"Weiller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Grateau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-7-20210309","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S1665-2681(19)32129-5","article-title":"Transthyretin familial amyloidotic polyneuropathy: histopathological study of the explanted livers.","volume":"2","author":"Amante","year":"2003","journal-title":"Ann Hepatol"},{"key":"R2-7-20210309","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.berh.2003.09.001","article-title":"The hereditary amyloidoses.","volume":"17","author":"Benson","year":"2003","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"R3-7-20210309","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/1098-1004(200008)16:2<180::AID-HUMU20>3.0.CO;2-#","article-title":"A novel variant of human lysozyme (T70N) is common in the normal population.","volume":"16","author":"Booth","year":"2000","journal-title":"Hum Mutat"},{"key":"R4-7-20210309","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/385787a0","article-title":"Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis.","volume":"385","author":"Booth","year":"1997","journal-title":"Nature"},{"key":"R5-7-20210309","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1172\/JCI118725","article-title":"Hereditary hepatic and systemic amyloidosis caused by a new deletion\/insertion mutation in the apolipoprotein AI gene.","volume":"97","author":"Booth","year":"1996","journal-title":"J Clin Invest"},{"key":"R6-7-20210309","doi-asserted-by":"crossref","first-page":"6419","DOI":"10.1021\/bi983037t","article-title":"Mechanistic studies of the folding of human lysozyme and the origin of amyloidogenic behavior in its disease-related variants.","volume":"38","author":"Canet","year":"1999","journal-title":"Biochemistry"},{"key":"R7-7-20210309","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1182\/blood.V97.6.1885","article-title":"Acquired factor X deficiency in patients with amyloid light-chain amyloidosis: incidence, bleeding manifestations, and response to high-dose chemotherapy.","volume":"97","author":"Choufani","year":"2001","journal-title":"Blood"},{"key":"R8-7-20210309","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/bss0680001","article-title":"Protein folding and its links with human disease.","volume":"68","author":"Dobson","year":"2001","journal-title":"Biochem Soc Symp"},{"key":"R9-7-20210309","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/nature01870","article-title":"A camelid antibody fragment inhibits the formation of amyloid fibrils by human lysozyme.","volume":"424","author":"Dumoulin","year":"2003","journal-title":"Nature"},{"key":"R10-7-20210309","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1093\/oxfordjournals.jbchem.a021544","article-title":"The structure, stability, and folding process of amyloidogenic mutant human lysozyme.","volume":"120","author":"Funahashi","year":"1996","journal-title":"J Biochem (Tokyo)"},{"key":"R11-7-20210309","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/ajh.2830370312","article-title":"Computed tomography for diagnosis of hepatic rupture in primary systemic amyloidosis.","volume":"37","author":"Gastineau","year":"1991","journal-title":"Am J Hematol"},{"key":"R12-7-20210309","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1093\/ndt\/14.11.2639","article-title":"Hereditary renal amyloidosis associated with variant lysozyme in a large English family.","volume":"14","author":"Gillmore","year":"1999","journal-title":"Nephrol Dial Transplant"},{"key":"R13-7-20210309","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1053\/gast.2002.36022","article-title":"A family with gastrointestinal amyloidosis associated with variant lysozyme.","volume":"123","author":"Granel","year":"2002","journal-title":"Gastroenterology"},{"key":"R14-7-20210309","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.amjmed.2004.10.022","article-title":"Underdiagnosed amyloidosis: amyloidosis of lysozyme variant.","volume":"118","author":"Granel B SJ, Valleix","year":"2005","journal-title":"Am J Med"},{"key":"R15-7-20210309","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/S1297-319X(02)00449-9","article-title":"Diagnostic tools for amyloidosis.","volume":"69","author":"Hachulla","year":"2002","journal-title":"Joint Bone Spine"},{"key":"R16-7-20210309","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1136\/gut.38.1.151","article-title":"'Fragile' liver and massive hepatic haemorrhage due to hereditary amyloidosis.","volume":"38","author":"Harrison","year":"1996","journal-title":"Gut"},{"key":"R17-7-20210309","first-page":"443","article-title":"Hereditary systemic amyloidosis with renal involvement.","volume":"16","author":"Hawkins","year":"2003","journal-title":"J Nephrol"},{"key":"R18-7-20210309","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1056\/NEJM199704243361702","article-title":"A trial of three regimens for primary amyloidosis: colchicine alone, melphalan and prednisone, and melphalan, prednisone, and colchicine.","volume":"336","author":"Kyle","year":"1997","journal-title":"N Engl J Med"},{"key":"R19-7-20210309","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1056\/NEJMoa013354","article-title":"Misdiagnosis of hereditary amyloidosis as AL (primary) amyloidosis.","volume":"346","author":"Lachmann","year":"2002","journal-title":"N Engl J Med"},{"key":"R20-7-20210309","first-page":"25","article-title":"Familial amyloidosis of Ostertag.","volume":"51","author":"Lanham","year":"1982","journal-title":"Q J Med"},{"key":"R21-7-20210309","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1056\/NEJMra023144","article-title":"Molecular mechanisms of amyloidosis.","volume":"349","author":"Merlini","year":"2003","journal-title":"N Engl J Med"},{"key":"R22-7-20210309","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1006\/jsbi.2000.4264","article-title":"Amyloid fibril formation and seeding by wild-type human lysozyme and its disease-related mutational variants.","volume":"130","author":"Morozova-Roche","year":"2000","journal-title":"J Struct Biol"},{"key":"R23-7-20210309","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1046\/j.1365-2141.2000.02183.x","article-title":"Bleeding symptoms and coagulation abnormalities in 337 patients with AL-amyloidosis.","volume":"110","author":"Mumford","year":"2000","journal-title":"Br J Haematol"},{"key":"R24-7-20210309","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/362553a0","article-title":"Human lysozyme gene mutations cause hereditary systemic amyloidosis.","volume":"362","author":"Pepys","year":"1993","journal-title":"Nature"},{"key":"R25-7-20210309","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/417254a","article-title":"Targeted pharmacological depletion of serum amyloid P component for treatment of human amyloidosis.","volume":"417","author":"Pepys","year":"2002","journal-title":"Nature"},{"key":"R26-7-20210309","first-page":"73","article-title":"Molecular mechanisms of fibrillogenesis and the protective role of amyloid P component: two possible avenues for therapy.","volume":"199","author":"Pepys","year":"1996","journal-title":"Ciba Found Symp"},{"key":"R27-7-20210309","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1111\/j.1572-0241.1998.00628.x","article-title":"Primary amyloidosis with spontaneaous splenic rupture, cholestasis, and liver failure with emergency liver transplantation.","volume":"93","author":"Sandberg-Gertzen","year":"1998","journal-title":"Am J Gastroenteraol"},{"key":"R28-7-20210309","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1056\/NEJM200206063462312","article-title":"Sporadic cases of hereditary systemic amyloidosis.","volume":"346","author":"Saraiva","year":"2002","journal-title":"N Engl J Med"},{"key":"R29-7-20210309","doi-asserted-by":"crossref","first-page":"519","DOI":"10.3109\/10428199509112215","article-title":"Primary amyloidosis co-presenting with cervical and massive intra-abdominal lymphadenopathy.","volume":"19","author":"Segalov","year":"1995","journal-title":"Leuk Lymphoma"},{"key":"R30-7-20210309","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1002\/art.1780220821","article-title":"Primary amyloidosis resembling sicca syndrome.","volume":"22","author":"Simon","year":"1979","journal-title":"Arthritis Rheum"},{"key":"R31-7-20210309","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1046\/j.1523-1755.2002.00205.x","article-title":"Hereditary renal amyloidosis caused by a new variant lysozyme W64R in a French family.","volume":"61","author":"Valleix","year":"2002","journal-title":"Kidney Int"},{"key":"R32-7-20210309","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1046\/j.1523-1755.2003.00904.x","article-title":"A novel lysozyme mutation Phe57Ile associated with hereditary renal amyloidosis.","volume":"63","author":"Yazaki","year":"2003","journal-title":"Kidney Int"},{"key":"R33-7-20210309","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1001\/jama.1983.03330340064034","article-title":"Bleeding manifestations in 100 patients with amyloidosis.","volume":"249","author":"Yood","year":"1983","journal-title":"JAMA"},{"key":"R34-7-20210309","first-page":"945","article-title":"Familial nephropathic non-neuropathic amyloidosis: clinical features, immunohistochemistry and chemistry.","volume":"81","author":"Zalin","year":"1991","journal-title":"Q J Med"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00006534-200510000-00017","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T15:10:03Z","timestamp":1785856203000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00005792-200601000-00007"}},"subtitle":["Report of 4 Cases and a Review of the Literature"],"short-title":[],"issued":{"date-parts":[[2006,1]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006]]}},"URL":"https:\/\/doi.org\/10.1097\/01.md.0000200467.51816.6d","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2006,1]]}}}